國立虎尾科技大學 |

High Density Lipoproteins = From Biological Understanding to Clinical Exploitation /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	High Density Lipoproteins/ edited by Arnold von Eckardstein, Dimitris Kardassis.
其他題名:	From Biological Understanding to Clinical Exploitation /
其他作者:	von Eckardstein, Arnold.
面頁冊數:	XIII, 694 p. 40 illus., 37 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-319-09665-0
ISBN:	9783319096650

High Density Lipoproteins = From Biological Understanding to Clinical Exploitation /
High Density LipoproteinsFrom Biological Understanding to Clinical Exploitation /[electronic resource] :edited by Arnold von Eckardstein, Dimitris Kardassis. - 1st ed. 2015. - XIII, 694 p. 40 illus., 37 illus. in color.online resource. - Handbook of Experimental Pharmacology,2240171-2004 ;. - Handbook of Experimental Pharmacology,224.

Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.

Open Access

In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

ISBN: 9783319096650

Standard No.: 10.1007/978-3-319-09665-0doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

High Density Lipoproteins = From Biological Understanding to Clinical Exploitation /
LDR:02471nam a22004335i 4500 001 960224
003 DE-He213
005 20200701085324.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319096650 $9 978-3-319-09665-0
024 7 $a 10.1007/978-3-319-09665-0 $2 doi
035 $a 978-3-319-09665-0
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a High Density Lipoproteins $h [electronic resource] : $b From Biological Understanding to Clinical Exploitation / $c edited by Arnold von Eckardstein, Dimitris Kardassis.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XIII, 694 p. 40 illus., 37 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224
505 0 $a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
506 0 $a Open Access
520 $a In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
650 0 $a Pharmacology. $3 583819
650 0 $a Molecular biology. $3 583443
650 0 $a Human physiology. $3 636012
650 0 $a Immunology. $3 592892
650 0 $a Cell biology. $3 1253486
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Human Physiology. $3 668349
650 2 4 $a Cell Biology. $3 593889
700 1 $a von Eckardstein, Arnold. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1254014
700 1 $a Kardassis, Dimitris. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064868
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319096667
776 0 8 $i Printed edition: $z 9783319096643
776 0 8 $i Printed edition: $z 9783319348612
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-319-09665-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
912 $a ZDB-2-SOB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)